BDBM327995 N-(2-(4-cyanobenzyl)- 1,2,3,4- tetrahydroisoquinolin-7- yl)-5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)picolinamide::US9663496, Compound 132

SMILES Fc1ccc(CC2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc3CCN(Cc4ccc(cc4)C#N)Cc3c2)cc1

InChI Key InChIKey=UMVLFDRMEJXDJL-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 327995   

Target5'-AMP-activated protein kinase catalytic subunit alpha-2(Human)
Rigel Pharmaceuticals

US Patent
LigandPNGBDBM327995(US9663496, Compound 132 | N-(2-(4-cyanobenzyl)- 1,...)
Affinity DataEC50: <500nMAssay Description:Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
US Patent